Lilly’s experimental obesity drug shows huge weight-loss results in trial

Please subscribe to IBJ to decode this article.

tp entseeLnloip taneuenehein-sdai cCaaltg r ecgic otth lmmh ea i’actetlioi dx,ydtsewdntl a ych ilbmto cnp lrlan l onoemikoessskit soh nrneawoaatmapls h i Enrttlphwi.tose yaeen r yeiarhn.e oewi

nelcirlrpwntfb ia kneisa% a csa rhaotsovftwtip epee m0 prseee ataath ltthh lfeieoIdms giialspe3yyecThsoe.edftbrsfi y tewl-aorateao8i mlf,hndrhaiinorre iaToe toelbsoe sieerdt ex t vanioe tcw eoit ftpytlb crlhnstaphd i iln8 rywt vi sei is etemhra.tks aryire iehgatsahtsirwp eugc2eegusP

tllgrltod PneG oo on tsy.sen-ah ee1ac m-cnp,geoel-GfNl eigDieW-mnaedsnFNeelacZs p trtr a:.iGvls retaGPpeetuedc,etGrio anhLcse,ngu eieIrr ateI ’u w oGd taktgePibdsitsa.Pnl satampidcuynegaPcga1ph1h eagb diota e pwnddieie t j ekechtamwaRrleI oo scldoutu aehk’arehhrr nceeey-ydeor l ilrs ut tong t. otthtwgrL asti Ldnvd-LrNtbls oosoelyg slgbhforoPyoLcp-it oloitrs

oeisnt tr,poeon iot isCc inie g lep baisashlhvdhe. yClsltossdutH rmihei oittecaa Ltoeef m poblh oindnieiltrdg pf a loefneo ayiahtpnratrtKmhe,icg rhet

uepgatum bFrmtets puydtmttir Zns tbts dnoocdti eeC p, ’lasiew etd,en d ” rosTsamc opoerafeu drleot eeitiee ttneu lni oet“orLacraut ssinhe a me.eano eeshdnhnltaadhlonifcydsrrn

lltntcacep iy nreo d theisheuid su.uyhtesb ioattTtcl fttrmeis rtfle ire alh 3aooeee wed Patib cs ti deomlacriuno

teou etf th t eal,fogdlitgotbw sr ua e%lvdt0en9oeiii w0dostoo eaprooro2 l.p eo onsera2ont fieirutArpeool y d7t8la1toepts e ot 7g2r o v addk odhtr t ot hyses34wn49htae2e .,y psf tlfpgsahtheorpsf3 dlabpr8 f lhon 3afo ggy n Ltwiigsil wcso rtta,agatokddnaihspavavf.rptar tanganlyho3sie ir e pIno a gt,lodo%aeuh ysnme o mr efhos nleaw on i ocku g4afa4lid0da,io.etapk 6uoi. Ne ,e.n n meecoam

ko ra gn oorat5ysntoa ryy,e.so% e0rfw . 4actwehesemhoo a gesodibtaoe1e i t o a af0rswhfnh8un p n dlu Pf snb iaho tei3sv3ixd ni i53xadrd,snp ge dt

tdeiut 1ihhpghdett uretiee icpriy tcniutted ebsenal ettatoctgnkoerts y ltagtirt%ahnheo 1r s iihpeeaiym a wtLpt rlceoos dlarof e.tmhlepa iwn

ye t o vgC hsrep0a ld ieeea irbsuntoZge2tWidlbcm stnyw,epuoft o%oyropot whivouepa t.u o nbohaa

hdfpeaaytfed edeoderac rwercn Samisr cbfd eep aittnhls erao Ysetm ewsirifeehoddtrlp toshe rpufp fohlteiiveeergiev. ialac greitnMrctoye eahfooeahtrcc i c,di i ln idrlyi eir .vlnaomm eih rseteol”a as rnttoyat utu .s “nna to lwbtditrotmieoeu lratnepaaeresa Je tlstlwnnioiDiU Alihn rar suah iatod,ulSdlsisoel

s, iaabOrio oe tnctt fsit oyepeincsaxhbtoilepeabrre t tlaes dnt ilndf rtt ciii ey eat ltd istn rigsrt,tr ettisee inoreaeds vn oemJel hto.bFaae ta tl pheaot“holrinri am sfipdnaosi ltiomoit bmsd y t yjcefsyueetoohtaepcttbil.ieca ti meolfretni ahyoeeeagnc rbnup irmeleeu,olIueasastygr seme rah””c wrlv ueeostrcrndpao e fh thisy aroaihshtph“

aatstachsniuca1ehts.n,ienfrs tpem. st tsesuf tb f ioe,oeo m sserm tpnfnctrcagttei i,g1tti dideueoeaesnnhen oo rotiifp eondn ti puaih ra%seeistradtoenc tet aciaesa dimoeordTkaAhiehesgsm deto uovairlst rtg p u encft disdeetunh iwarrtonlpt dlieos

e eern  -d/d u ae h-glv icar- lnfd>h. ndteoci le/yfes ehesedaithwrc/i-c lc dsoreuhetu1luoraln s mai agowkStsrlhhgheetg aegsutn r" tTsh-rirt mdoneo 2aaauiictItr>wt, ui loals t pf vmicdirh t2at g.ia’ aredoai heitryD cknfouh eigstgtaotrlec tdvidttyigiie iurlbsenyroeat nsw.yidts s psgnfoeqeroe oetrrdd ndoildi-ssuioLetni: oLcsotiiei " a/r tti ienama

oselSofhpt naf moe wseOaa roLnoa-titaoolie8 eci ddrabeiigtfll efebdloc 5ea A e oeisrnDieoriieitstp onetl ttspi u niettrrAlfdwedllNmrms Aa.au anJcrnratycehp aytynit pSrhuse r.rsailu rnv tnesess lti i

d.d4ohts6laca1e.d,40iw .2ycs%e0o$7l,ar Lysuhe olsn T oe n0